S.975 - Project BioShield II Act of 2005

A bill to provide incentives to increase research by private sector entities to develop medical countermeasures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak, and for other purposes. view all titles (3)

All Bill Titles

  • Short: Project BioShield II Act of 2005 as introduced.
  • Short: BioShield Export Priority Act as introduced.
  • Official: A bill to provide incentives to increase research by private sector entities to develop medical countermeasures to prevent, detect, identify, contain, and treat illnesses, including those associated with biological, chemical, nuclear, or radiological weapons attack or an infectious disease outbreak, and for other purposes. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 1
  • All-Time: 847
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
04/28/05
 
 
 
 
 
 
 

Official Summary

Project BioShield II Act of 2005 - Establishes: (1) the Terrorism and Infectious Disease Countermeasure Purchase Fund; (2) procurement pools for qualified countermeasures and security countermeasures; (3) the International Public Health Advisory Committee to develop strategies for establish

Official Summary

Project BioShield II Act of 2005 - Establishes:
(1) the Terrorism and Infectious Disease Countermeasure Purchase Fund;
(2) procurement pools for qualified countermeasures and security countermeasures;
(3) the International Public Health Advisory Committee to develop strategies for establishing such pools;
(4) the Office of Public Health Countermeasure Development within the Department of Health and Human Services (HHS) ;
(5) the Office of Medical Readiness within the Office of the Secretary of the Department of Homeland Security (DHS) to assume functions of the National Disaster Medical System and the Metropolitan Medical Response System;
(6) the National Emergency Medical Readiness and Response Board within DHS to oversee emergency medical response plans;
(7) the National Center for Healthcare Technology Development to manage NIH intellectual property;
(8) the Millennium Medicine Discovery Award;
(9) the Office of the Deputy Commissioner for Biological, Chemical, Nuclear, Radiological and Infectious Disease Products; and
(10) the Global Disease Detection Trust Fund. Creates incentives for the development of countermeasures, including:
(1) payments to manufacturers;
(2) accelerated approval of countermeasures;
(3) patent term restoration and extension;
(4) exclusive marketing;
(5) federal tax incentives;
(6) reimbursements for production costs;
(7) expedited processing of visa applications;
(8) grants and contracts for the construction and management of biosafety level 3-4 facilities; and
(9) grants and scholarships for personnel to conduct biodefense and infectious disease research. Sets forth provisions regarding necessary research for countermeasure development, including research regarding:
(1) diagnostics;
(2) detection technology;
(3) infectious diseases;
(4) accurate animal models;
(5) biologics;
(6) vaccine adjuvants;
(7) the production of cell culture;
(8) vaccines;
(9) zoonotic disease surveillance; and
(10) agroterrorism research. Bioshield Export Priority Act - Requires the Secretary of Commerce or the Secretary of Health and Human Services to expedite the processing of requests to export restricted items necessary to procure countermeasures.

...Read the Rest




Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC